Early-demographic dividend vs Iran: Immunization, HepB3 (% of one-year-old children)
Early-demographic dividend
86.7%
in 2024
Iran
98.0%
in 2024
Early-demographic dividend rank
20th
Iran rank
19th
Immunization, HepB3 (% of one-year-old children) over time
- Early-demographic dividend
- Iran
How they compare
Iran currently reports 98.0% against 86.7% in Early-demographic dividend, a difference of 11.3%.
That makes Iran's figure about 1.1 times Early-demographic dividend's.
Across all 31 years both countries report, Iran has been ahead every year.
Early-demographic dividend ranks 20th and Iran ranks 19th of 47 groups.
Iran has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Early-demographic dividend | Iran | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 12.2% | 81.2% | 69.0% | Iran |
| 2000s | 39.7% | 97.2% | 57.5% | Iran |
| 2010s | 79.5% | 98.8% | 19.3% | Iran |
| 2020s | 84.9% | 98.6% | 13.7% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Early-demographic dividend or Iran?
- Iran, at 98.0% against 86.7% in Early-demographic dividend as of 2024.
- What is the difference in immunization, hepb3 between Early-demographic dividend and Iran?
- 11.3%, with Iran ahead.
- How many years of comparable data are there for Early-demographic dividend and Iran?
- 31 years are reported by both, from 1994 to 2024.
- How do Early-demographic dividend and Iran rank globally for immunization, hepb3?
- Early-demographic dividend ranks 20th and Iran ranks 19th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.